Aatec Medical and SPRIND collaborate to advance ATL-105 for viral respiratory diseases
Feb. 7, 2024
Aatec Medical GmbH has announced the start of its collaboration with the German Federal Agency for Disruptive Innovations (SPRIND), which will help advance the preclinical development of ATL-105.